is glp 1 safe for kidney disease GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes GLP-1 drugs may extend life,

Thats why the FDAs own technical staff has recommended against expanded access, and the public health group Partnership for Safe Medicines calls them "popular, unproven, dangerous. As Peter Kolchinsky, managing partner of biotech investor RA Capital Management, puts it: Is the FDA going to stand on science or is it going to permit all kinds of snake oil to be readily available? The FDA meeting will last two days

As clinicians, recognizing that people can get double benefits from something is always helpful and as more obesity medications enter the market, this can help personalize treatments, she said

Without them, much of that water passes straight through

That tension defines much of the current BPC-157 landscape